TR4, as an orphan nuclear receptor without an identified ligand, has been proved to play an important role in tumorigenesis and tumor progression, including prostate cancer Lin et al. (2015b), renal cell carcinoma Bai et al. (2018), and hepatocellular carcinoma (Jin et al., 2018). This evidence concerns the gene ESRRB and prostate carcinoma.